Sandostatine Long Acting Repeatable 10 mg inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Octreotide Acetate 11,2 mg - Eq. Octreotide 10 mg
Available from:
Novartis Pharma SA-NV
ATC code:
H01CB02
INN (International Name):
Octreotide Acetate
Dosage:
10 mg
Pharmaceutical form:
Powder and solvent for suspension for injection
Composition:
Octreotide Acetate 11.2 mg
Administration route:
Intramuscular use
Therapeutic area:
Octreotide
Product summary:
CTI code: 191746-01 - Pack size: 10 mg + 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription
Authorization status:
Commercialised: No
Authorization date:
1998-02-24
